Prelude Capital Management’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
SG
Prelude Capital Management's PTEN Position: Q4 2025 in Review
Prelude Capital Management sold out of Patterson-UTI (PTEN) in Q4 2025, closing a stake of 42,465 shares — an estimated $220K sold.
Prelude Capital Management first reported a position in PTEN in Q2 2013 and held it in 20 quarters. The position peaked at $2.06M in Q4 2017. 372 funds tracked by Wall St. Rank hold PTEN as of Q4 2025.
- Prelude Capital Management reported no remaining Patterson-UTI position as of Q4 2025 after selling out during the quarter.
- Prelude Capital Management sold 42,465 Patterson-UTI shares in Q4 2025, an estimated $220K.
- Prelude Capital Management first reported a position in Patterson-UTI in Q2 2013 and held it in 20 quarters.
- Prelude Capital Management's Patterson-UTI position peaked at $2.06M in Q4 2017.
- 372 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2025.
Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.